• 1
    Health Protection Agency. 2012. HIV in the United Kingdom: 2012 Report.
  • 2
    Tookey P, MRC Centre of Epidemiology for Child Health, UCL Institute of Child Health London. Obstetric and paediatric HIV surveillance data from the UK and Ireland. NSHPC 2012.
  • 3
    Chadborn TR, Delpech VC, Sabin CA, Sinka K, Evans BG. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals. AIDS 2006; 20: 23712379.
  • 4
    Nakagawa F, Lodwick RK, Smith CJ et al. Projected life expectancy of people with HIV according to timing of diagnosis. AIDS 2012; 26: 335343.
  • 5
    Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20: 14471450.
  • 6
    British HIV Association. 2008. UK National Guidelines for HIV Testing.
  • 7
    National Institute for Health and Clinical Excellence. 2011. Increasing the uptake of HIV testing to reduce undiagnosed infection and prevent transmission among men who have sex with men.
  • 8
    Ellis S, Curtis H, Ong ELC. HIV diagnoses and missed opportunities. Results of the British HIV Association (BHIVA) National Audit 2010. Clin Med 2012; 12: 430434.
  • 9
    Tweed E, Hale A, Hurrelle M et al. Monitoring HIV testing in diverse healthcare settings: results from a sentinel surveillance pilot study. Sex Transm Infect 2010; 86: 360364.
  • 10
    Alston C, Moffatt D, Asherson A, Powell N, Narouz N. HIV testing in medical admissions is a missed opportunity. Clin Med 2013; 13: 114.
  • 11
    Burns FM, Johnson AM, Nazroo J et al. Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK. AIDS 2008; 22: 115122.
  • 12
    Department of Health. The Public Health Outcomes Framework for England 2013–2016, published 2012; Available at (accessed 5 June 2013).
  • 13
    Paltiel AD, Weinstein MC, Kimmel AD et al. Expanded screening for HIV in the United States – an analysis of cost-effectiveness. N Engl J Med 2005; 352: 586595.
  • 14
    Walensky RP, Freedberg KA, Weinstein MC, Paltiel AD. Cost-effectiveness of HIV testing and treatment in the United States. Clin Infect Dis 2007; 45 (Suppl 4): S248S254.
  • 15
    Phillips AN, Cambiano V, Nakagawa F et al. Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic. PLoS ONE 2013; 8: e55312.
  • 16
    Health Protection Agency. 2011. Time to test for HIV?: Expanding HIV testing in healthcare and community services in England.
  • 17
    Rayment M, Thornton A, Mandalia S et al. HIV testing in non-traditional settings–the HINTS study: a multi-centre observational study of feasibility and acceptability. PLoS ONE 2012; 7: e39530.
  • 18
    Prost A, Griffiths CJ, Anderson J, Wight D, Hart GJ. Feasibility and acceptability of offering rapid HIV tests to patients registering with primary care in London (UK): a pilot study. Sex Transm Infect 2009; 85: 326329.
  • 19
    Palfreeman A, Nyatsanza F, Farn H, McKinnon G, Schober P, McNally P. HIV testing for acute medical admissions: evaluation of a pilot study in Leicester, England. Sex Transm Infect 2012; 7: 13.
  • 20
    Flowers P, Knussen C, Li J, McDaid L. Has testing been normalized? An analysis of changes in barriers to HIV testing among men who have sex with men between 2000 and 2010 in Scotland, UK. HIV Med 2013; 14: 9298.